Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)

Clinical trial NCT01669811 · COMPLETED

Trial details

NCT number: NCT01669811
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Reflux Esophagitis

Start date: 2012-08-01
Primary completion: 2014-05-01
Enrollment: 1398

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.